Dáil Éireann Debate, Tuesday - 28 November 2017
323. Deputy Billy Kelleher asked the Minister for Health the outcome of the meeting between a company (details supplied) and the HSE in recent days regarding the drug Vimizim for the treatment of Morquio disease; and if he will make a statement on the matter. [49906/17]
Amharc ar fhreagra398. Deputy Kathleen Funchion asked the Minister for Health if the HSE drugs committee group met on 14 September 2017; if the drug Vimizim was discussed; if a decision was made to reimburse the drug; and if he will make a statement on the matter. [50276/17]
Amharc ar fhreagraI propose to take Questions Nos. 323 and 398 together.
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the pricing and reimbursement of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
